Skip to main content
Premium Trial:

Request an Annual Quote

OPX Lands $3.6M in Venture Financing to Support Biofuel Genomics

NEW YORK (GenomeWeb News) - OPX Biotechnologies has received $3.6 million in its second round of venture financing, which was led by Mohr Davidow Ventures.
 
Other investors in the round included X/Seed Capital, which provided OPX’s seed financing in June 2007, and Robert Chess, who has been named OPX CEO and chairman.
 
Boulder, Colo.-based OPX is developing genomics technologies designed for microbial biofuel development.
 
OPX’s set of tools and intellectual property, called SCALEs, enable massively parallel full genome search, identification of specific causative genes, and rapid genetic modification and testing, the company said. These tools are used to design new microbes that would improve tolerance, productivity, and specificity for fuel and chemicals production.
 
Chess said the SCALEs technology can “identify the role of each gene and how to modify it to achieve the characteristics needed for specific fuel and chemical products 1,000 to 5,000 times faster than conventional methods.”

The Scan

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.